市場調査レポート
商品コード
1473623
経口メロキシカムの世界市場に関する洞察、2030年までの予測Global Oral Meloxicam Market Insights, Forecast to 2030 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
経口メロキシカムの世界市場に関する洞察、2030年までの予測 |
出版日: 2024年05月07日
発行: QYResearch
ページ情報: 英文 149 Pages
納期: 2~3営業日
|
当レポートは、経口メロキシカム (Oral Meloxicam) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。
Table 1. Global Oral Meloxicam Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Table 2. Major Manufacturers of Tablets
Table 3. Major Manufacturers of Capsules
Table 4. Global Oral Meloxicam Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Table 5. Global Oral Meloxicam Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 6. Global Oral Meloxicam Revenue by Region (2019-2024) & (US$ Million)
Table 7. Global Oral Meloxicam Revenue by Region (2025-2030) & (US$ Million)
Table 8. Global Oral Meloxicam Revenue Market Share by Region (2019-2024)
Table 9. Global Oral Meloxicam Revenue Market Share by Region (2025-2030)
Table 10. Global Oral Meloxicam Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (K Units)
Table 11. Global Oral Meloxicam Sales by Region (2019-2024) & (K Units)
Table 12. Global Oral Meloxicam Sales by Region (2025-2030) & (K Units)
Table 13. Global Oral Meloxicam Sales Market Share by Region (2019-2024)
Table 14. Global Oral Meloxicam Sales Market Share by Region (2025-2030)
Table 15. Global Oral Meloxicam Sales by Manufacturers (2019-2024) & (K Units)
Table 16. Global Oral Meloxicam Sales Share by Manufacturers (2019-2024)
Table 17. Global Oral Meloxicam Revenue by Manufacturers (2019-2024) & (US$ Million)
Table 18. Global Oral Meloxicam Revenue Market Share by Manufacturers (2019-2024)
Table 19. Global Key Players of Oral Meloxicam, Industry Ranking, 2021 VS 2022 VS 2023
Table 20. Oral Meloxicam Price by Manufacturers (2019-2024) & (US$/Unit)
Table 21. Global Oral Meloxicam Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Oral Meloxicam by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Meloxicam as of 2023)
Table 23. Global Key Manufacturers of Oral Meloxicam, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Oral Meloxicam, Product Offered and Application
Table 25. Global Key Manufacturers of Oral Meloxicam, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Oral Meloxicam Sales by Type (2019-2024) & (K Units)
Table 28. Global Oral Meloxicam Sales by Type (2025-2030) & (K Units)
Table 29. Global Oral Meloxicam Sales Share by Type (2019-2024)
Table 30. Global Oral Meloxicam Sales Share by Type (2025-2030)
Table 31. Global Oral Meloxicam Revenue by Type (2019-2024) & (US$ Million)
Table 32. Global Oral Meloxicam Revenue by Type (2025-2030) & (US$ Million)
Table 33. Global Oral Meloxicam Revenue Share by Type (2019-2024)
Table 34. Global Oral Meloxicam Revenue Share by Type (2025-2030)
Table 35. Oral Meloxicam Price by Type (2019-2024) & (US$/Unit)
Table 36. Global Oral Meloxicam Price Forecast by Type (2025-2030) & (US$/Unit)
Table 37. Global Oral Meloxicam Sales by Application (2019-2024) & (K Units)
Table 38. Global Oral Meloxicam Sales by Application (2025-2030) & (K Units)
Table 39. Global Oral Meloxicam Sales Share by Application (2019-2024)
Table 40. Global Oral Meloxicam Sales Share by Application (2025-2030)
Table 41. Global Oral Meloxicam Revenue by Application (2019-2024) & (US$ Million)
Table 42. Global Oral Meloxicam Revenue by Application (2025-2030) & (US$ Million)
Table 43. Global Oral Meloxicam Revenue Share by Application (2019-2024)
Table 44. Global Oral Meloxicam Revenue Share by Application (2025-2030)
Table 45. Oral Meloxicam Price by Application (2019-2024) & (US$/Unit)
Table 46. Global Oral Meloxicam Price Forecast by Application (2025-2030) & (US$/Unit)
Table 47. US & Canada Oral Meloxicam Sales by Type (2019-2024) & (K Units)
Table 48. US & Canada Oral Meloxicam Sales by Type (2025-2030) & (K Units)
Table 49. US & Canada Oral Meloxicam Revenue by Type (2019-2024) & (US$ Million)
Table 50. US & Canada Oral Meloxicam Revenue by Type (2025-2030) & (US$ Million)
Table 51. US & Canada Oral Meloxicam Sales by Application (2019-2024) & (K Units)
Table 52. US & Canada Oral Meloxicam Sales by Application (2025-2030) & (K Units)
Table 53. US & Canada Oral Meloxicam Revenue by Application (2019-2024) & (US$ Million)
Table 54. US & Canada Oral Meloxicam Revenue by Application (2025-2030) & (US$ Million)
Table 55. US & Canada Oral Meloxicam Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 56. US & Canada Oral Meloxicam Revenue by Country (2019-2024) & (US$ Million)
Table 57. US & Canada Oral Meloxicam Revenue by Country (2025-2030) & (US$ Million)
Table 58. US & Canada Oral Meloxicam Sales by Country (2019-2024) & (K Units)
Table 59. US & Canada Oral Meloxicam Sales by Country (2025-2030) & (K Units)
Table 60. Europe Oral Meloxicam Sales by Type (2019-2024) & (K Units)
Table 61. Europe Oral Meloxicam Sales by Type (2025-2030) & (K Units)
Table 62. Europe Oral Meloxicam Revenue by Type (2019-2024) & (US$ Million)
Table 63. Europe Oral Meloxicam Revenue by Type (2025-2030) & (US$ Million)
Table 64. Europe Oral Meloxicam Sales by Application (2019-2024) & (K Units)
Table 65. Europe Oral Meloxicam Sales by Application (2025-2030) & (K Units)
Table 66. Europe Oral Meloxicam Revenue by Application (2019-2024) & (US$ Million)
Table 67. Europe Oral Meloxicam Revenue by Application (2025-2030) & (US$ Million)
Table 68. Europe Oral Meloxicam Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 69. Europe Oral Meloxicam Revenue by Country (2019-2024) & (US$ Million)
Table 70. Europe Oral Meloxicam Revenue by Country (2025-2030) & (US$ Million)
Table 71. Europe Oral Meloxicam Sales by Country (2019-2024) & (K Units)
Table 72. Europe Oral Meloxicam Sales by Country (2025-2030) & (K Units)
Table 73. China Oral Meloxicam Sales by Type (2019-2024) & (K Units)
Table 74. China Oral Meloxicam Sales by Type (2025-2030) & (K Units)
Table 75. China Oral Meloxicam Revenue by Type (2019-2024) & (US$ Million)
Table 76. China Oral Meloxicam Revenue by Type (2025-2030) & (US$ Million)
Table 77. China Oral Meloxicam Sales by Application (2019-2024) & (K Units)
Table 78. China Oral Meloxicam Sales by Application (2025-2030) & (K Units)
Table 79. China Oral Meloxicam Revenue by Application (2019-2024) & (US$ Million)
Table 80. China Oral Meloxicam Revenue by Application (2025-2030) & (US$ Million)
Table 81. Asia Oral Meloxicam Sales by Type (2019-2024) & (K Units)
Table 82. Asia Oral Meloxicam Sales by Type (2025-2030) & (K Units)
Table 83. Asia Oral Meloxicam Revenue by Type (2019-2024) & (US$ Million)
Table 84. Asia Oral Meloxicam Revenue by Type (2025-2030) & (US$ Million)
Table 85. Asia Oral Meloxicam Sales by Application (2019-2024) & (K Units)
Table 86. Asia Oral Meloxicam Sales by Application (2025-2030) & (K Units)
Table 87. Asia Oral Meloxicam Revenue by Application (2019-2024) & (US$ Million)
Table 88. Asia Oral Meloxicam Revenue by Application (2025-2030) & (US$ Million)
Table 89. Asia Oral Meloxicam Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 90. Asia Oral Meloxicam Revenue by Region (2019-2024) & (US$ Million)
Table 91. Asia Oral Meloxicam Revenue by Region (2025-2030) & (US$ Million)
Table 92. Asia Oral Meloxicam Sales by Region (2019-2024) & (K Units)
Table 93. Asia Oral Meloxicam Sales by Region (2025-2030) & (K Units)
Table 94. Middle East, Africa and Latin America Oral Meloxicam Sales by Type (2019-2024) & (K Units)
Table 95. Middle East, Africa and Latin America Oral Meloxicam Sales by Type (2025-2030) & (K Units)
Table 96. Middle East, Africa and Latin America Oral Meloxicam Revenue by Type (2019-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Oral Meloxicam Revenue by Type (2025-2030) & (US$ Million)
Table 98. Middle East, Africa and Latin America Oral Meloxicam Sales by Application (2019-2024) & (K Units)
Table 99. Middle East, Africa and Latin America Oral Meloxicam Sales by Application (2025-2030) & (K Units)
Table 100. Middle East, Africa and Latin America Oral Meloxicam Revenue by Application (2019-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Oral Meloxicam Revenue by Application (2025-2030) & (US$ Million)
Table 102. Middle East, Africa and Latin America Oral Meloxicam Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 103. Middle East, Africa and Latin America Oral Meloxicam Revenue by Country (2019-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Oral Meloxicam Revenue by Country (2025-2030) & (US$ Million)
Table 105. Middle East, Africa and Latin America Oral Meloxicam Sales by Country (2019-2024) & (K Units)
Table 106. Middle East, Africa and Latin America Oral Meloxicam Sales by Country (2025-2030) & (K Units)
Table 107. Boehringer Ingelheim Company Information
Table 108. Boehringer Ingelheim Description and Major Businesses
Table 109. Boehringer Ingelheim Oral Meloxicam Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 110. Boehringer Ingelheim Oral Meloxicam Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Boehringer Ingelheim Recent Developments
Table 112. Mylan Company Information
Table 113. Mylan Description and Major Businesses
Table 114. Mylan Oral Meloxicam Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 115. Mylan Oral Meloxicam Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Mylan Recent Developments
Table 117. Teva Pharmaceutical Company Information
Table 118. Teva Pharmaceutical Description and Major Businesses
Table 119. Teva Pharmaceutical Oral Meloxicam Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 120. Teva Pharmaceutical Oral Meloxicam Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Teva Pharmaceutical Recent Developments
Table 122. Lupin Company Information
Table 123. Lupin Description and Major Businesses
Table 124. Lupin Oral Meloxicam Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 125. Lupin Oral Meloxicam Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Lupin Recent Developments
Table 127. Apotex Company Information
Table 128. Apotex Description and Major Businesses
Table 129. Apotex Oral Meloxicam Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 130. Apotex Oral Meloxicam Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Apotex Recent Developments
Table 132. Dr. Reddy's Laboratories Company Information
Table 133. Dr. Reddy's Laboratories Description and Major Businesses
Table 134. Dr. Reddy's Laboratories Oral Meloxicam Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 135. Dr. Reddy's Laboratories Oral Meloxicam Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Dr. Reddy's Laboratories Recent Developments
Table 137. Glenmark Pharmaceuticals Company Information
Table 138. Glenmark Pharmaceuticals Description and Major Businesses
Table 139. Glenmark Pharmaceuticals Oral Meloxicam Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 140. Glenmark Pharmaceuticals Oral Meloxicam Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Glenmark Pharmaceuticals Recent Developments
Table 142. Qilu Pharmaceutical Company Information
Table 143. Qilu Pharmaceutical Description and Major Businesses
Table 144. Qilu Pharmaceutical Oral Meloxicam Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 145. Qilu Pharmaceutical Oral Meloxicam Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Qilu Pharmaceutical Recent Developments
Table 147. Yangtze River Pharmaceutical Company Information
Table 148. Yangtze River Pharmaceutical Description and Major Businesses
Table 149. Yangtze River Pharmaceutical Oral Meloxicam Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 150. Yangtze River Pharmaceutical Oral Meloxicam Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Yangtze River Pharmaceutical Recent Developments
Table 152. Zhejiang Xianju Pharmaceutical Company Information
Table 153. Zhejiang Xianju Pharmaceutical Description and Major Businesses
Table 154. Zhejiang Xianju Pharmaceutical Oral Meloxicam Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 155. Zhejiang Xianju Pharmaceutical Oral Meloxicam Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Zhejiang Xianju Pharmaceutical Recent Developments
Table 157. Youcare Pharmaceutical Company Information
Table 158. Youcare Pharmaceutical Description and Major Businesses
Table 159. Youcare Pharmaceutical Oral Meloxicam Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 160. Youcare Pharmaceutical Oral Meloxicam Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. Youcare Pharmaceutical Recent Developments
Table 162. Key Raw Materials Lists
Table 163. Raw Materials Key Suppliers Lists
Table 164. Oral Meloxicam Distributors List
Table 165. Oral Meloxicam Customers List
Table 166. Oral Meloxicam Market Trends
Table 167. Oral Meloxicam Market Drivers
Table 168. Oral Meloxicam Market Challenges
Table 169. Oral Meloxicam Market Restraints
Table 170. Research Programs/Design for This Report
Table 171. Key Data Information from Secondary Sources
Table 172. Key Data Information from Primary Sources
Figure 1. Oral Meloxicam Product Picture
Figure 2. Global Oral Meloxicam Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Oral Meloxicam Market Share by Type: 2023 & 2030
Figure 4. Tablets Product Picture
Figure 5. Capsules Product Picture
Figure 6. Global Oral Meloxicam Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 7. Global Oral Meloxicam Market Share by Application: 2023 & 2030
Figure 8. Rheumatoid Arthritis
Figure 9. Osteoarthritis
Figure 10. Oral Meloxicam Report Years Considered
Figure 11. Global Oral Meloxicam Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Oral Meloxicam Revenue (2019-2030) & (US$ Million)
Figure 13. Global Oral Meloxicam Revenue (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 14. Global Oral Meloxicam Revenue Market Share by Region in Percentage: 2023 Versus 2030
Figure 15. Global Oral Meloxicam Revenue Market Share by Region (2019-2030)
Figure 16. Global Oral Meloxicam Sales (2019-2030) & (K Units)
Figure 17. Global Oral Meloxicam Sales (CAGR) by Region: 2019 VS 2023 VS 2030 (K Units)
Figure 18. Global Oral Meloxicam Sales Market Share by Region (2019-2030)
Figure 19. US & Canada Oral Meloxicam Sales YoY (2019-2030) & (K Units)
Figure 20. US & Canada Oral Meloxicam Revenue YoY (2019-2030) & (US$ Million)
Figure 21. Europe Oral Meloxicam Sales YoY (2019-2030) & (K Units)
Figure 22. Europe Oral Meloxicam Revenue YoY (2019-2030) & (US$ Million)
Figure 23. China Oral Meloxicam Sales YoY (2019-2030) & (K Units)
Figure 24. China Oral Meloxicam Revenue YoY (2019-2030) & (US$ Million)
Figure 25. Asia (excluding China) Oral Meloxicam Sales YoY (2019-2030) & (K Units)
Figure 26. Asia (excluding China) Oral Meloxicam Revenue YoY (2019-2030) & (US$ Million)
Figure 27. Middle East, Africa and Latin America Oral Meloxicam Sales YoY (2019-2030) & (K Units)
Figure 28. Middle East, Africa and Latin America Oral Meloxicam Revenue YoY (2019-2030) & (US$ Million)
Figure 29. Global Oral Meloxicam Sales Share by Manufacturers (2023)
Figure 30. The Oral Meloxicam Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
Figure 31. Global Oral Meloxicam Revenue Share by Manufacturers (2023)
Figure 32. The Top 5 and 10 Largest Manufacturers of Oral Meloxicam in the World: Market Share by Oral Meloxicam Revenue in 2023
Figure 33. Global Oral Meloxicam Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 34. Global Oral Meloxicam Sales Market Share by Type (2019-2030)
Figure 35. Global Oral Meloxicam Revenue Market Share by Type (2019-2030)
Figure 36. Global Oral Meloxicam Sales Market Share by Application (2019-2030)
Figure 37. Global Oral Meloxicam Revenue Market Share by Application (2019-2030)
Figure 38. US & Canada Oral Meloxicam Sales Market Share by Type (2019-2030)
Figure 39. US & Canada Oral Meloxicam Revenue Market Share by Type (2019-2030)
Figure 40. US & Canada Oral Meloxicam Sales Market Share by Application (2019-2030)
Figure 41. US & Canada Oral Meloxicam Revenue Market Share by Application (2019-2030)
Figure 42. US & Canada Oral Meloxicam Revenue Share by Country (2019-2030)
Figure 43. US & Canada Oral Meloxicam Sales Share by Country (2019-2030)
Figure 44. US Oral Meloxicam Revenue (2019-2030) & (US$ Million)
Figure 45. Canada Oral Meloxicam Revenue (2019-2030) & (US$ Million)
Figure 46. Europe Oral Meloxicam Sales Market Share by Type (2019-2030)
Figure 47. Europe Oral Meloxicam Revenue Market Share by Type (2019-2030)
Figure 48. Europe Oral Meloxicam Sales Market Share by Application (2019-2030)
Figure 49. Europe Oral Meloxicam Revenue Market Share by Application (2019-2030)
Figure 50. Europe Oral Meloxicam Revenue Share by Country (2019-2030)
Figure 51. Europe Oral Meloxicam Sales Share by Country (2019-2030)
Figure 52. Germany Oral Meloxicam Revenue (2019-2030) & (US$ Million)
Figure 53. France Oral Meloxicam Revenue (2019-2030) & (US$ Million)
Figure 54. U.K. Oral Meloxicam Revenue (2019-2030) & (US$ Million)
Figure 55. Italy Oral Meloxicam Revenue (2019-2030) & (US$ Million)
Figure 56. Russia Oral Meloxicam Revenue (2019-2030) & (US$ Million)
Figure 57. China Oral Meloxicam Sales Market Share by Type (2019-2030)
Figure 58. China Oral Meloxicam Revenue Market Share by Type (2019-2030)
Figure 59. China Oral Meloxicam Sales Market Share by Application (2019-2030)
Figure 60. China Oral Meloxicam Revenue Market Share by Application (2019-2030)
Figure 61. Asia Oral Meloxicam Sales Market Share by Type (2019-2030)
Figure 62. Asia Oral Meloxicam Revenue Market Share by Type (2019-2030)
Figure 63. Asia Oral Meloxicam Sales Market Share by Application (2019-2030)
Figure 64. Asia Oral Meloxicam Revenue Market Share by Application (2019-2030)
Figure 65. Asia Oral Meloxicam Revenue Share by Region (2019-2030)
Figure 66. Asia Oral Meloxicam Sales Share by Region (2019-2030)
Figure 67. Japan Oral Meloxicam Revenue (2019-2030) & (US$ Million)
Figure 68. South Korea Oral Meloxicam Revenue (2019-2030) & (US$ Million)
Figure 69. China Taiwan Oral Meloxicam Revenue (2019-2030) & (US$ Million)
Figure 70. Southeast Asia Oral Meloxicam Revenue (2019-2030) & (US$ Million)
Figure 71. India Oral Meloxicam Revenue (2019-2030) & (US$ Million)
Figure 72. Australia Oral Meloxicam Revenue (2019-2030) & (US$ Million)
Figure 73. Middle East, Africa and Latin America Oral Meloxicam Sales Market Share by Type (2019-2030)
Figure 74. Middle East, Africa and Latin America Oral Meloxicam Revenue Market Share by Type (2019-2030)
Figure 75. Middle East, Africa and Latin America Oral Meloxicam Sales Market Share by Application (2019-2030)
Figure 76. Middle East, Africa and Latin America Oral Meloxicam Revenue Market Share by Application (2019-2030)
Figure 77. Middle East, Africa and Latin America Oral Meloxicam Revenue Share by Country (2019-2030)
Figure 78. Middle East, Africa and Latin America Oral Meloxicam Sales Share by Country (2019-2030)
Figure 79. Brazil Oral Meloxicam Revenue (2019-2030) & (US$ Million)
Figure 80. Mexico Oral Meloxicam Revenue (2019-2030) & (US$ Million)
Figure 81. Turkey Oral Meloxicam Revenue (2019-2030) & (US$ Million)
Figure 82. Israel Oral Meloxicam Revenue (2019-2030) & (US$ Million)
Figure 83. GCC Countries Oral Meloxicam Revenue (2019-2030) & (US$ Million)
Figure 84. Oral Meloxicam Value Chain
Figure 85. Oral Meloxicam Production Process
Figure 86. Channels of Distribution (Direct Vs Distribution)
Figure 87. Bottom-up and Top-down Approaches for This Report
Figure 88. Data Triangulation
Figure 89. Key Executives Interviewed
This research report focuses on the Oral Meloxicam Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.